V sou\u010dasn\u00e9 dob\u011b prob\u00edhaj\u00ed testy psilocybinu v n\u011bkolika klinick\u00fdch studi\u00edch a spole\u010dnostech v USA. Za\u010d\u00e1tkem leto\u0161n\u00edho roku z\u00edskala studie prov\u00e1d\u011bn\u00e1 spole\u010dnost\u00ed Compass Pathways, \"spole\u010dnost\u00ed zab\u00fdvaj\u00edc\u00ed se v\u011bdami o \u017eivot\u011b, jej\u00edm\u017e c\u00edlem je urychlit p\u0159\u00edstup pacient\u016f k inovac\u00edm zalo\u017een\u00fdm na d\u016fkazech v oblasti du\u0161evn\u00edho zdrav\u00ed\", ozna\u010den\u00ed \"pr\u016flomov\u00e1 terapie\" pro svou prob\u00edhaj\u00edc\u00ed inovativn\u00ed terapii, kter\u00e1 se to\u010d\u00ed kolem psilocybinu. C\u00edlem studie ozna\u010dovan\u00e9 jako \"psilocybinov\u00e1 terapie\" je zjistit, jak psilocybin dok\u00e1\u017ee l\u00e9\u010dit t\u011b\u017ek\u00e9 p\u0159\u00edpady deprese, u nich\u017e pacient nereaguje na jin\u00e9 formy l\u00e9\u010dby. V podstat\u011b se jedn\u00e1 o posledn\u00ed mo\u017enost pro pacienty.<\/p>\n
Dnes prob\u00edhaj\u00edc\u00ed studii provozuje Usona Institute se s\u00eddlem ve Wisconsinu, \"neziskov\u00e1 l\u00e9ka\u0159sk\u00e1 v\u00fdzkumn\u00e1 organizace\", kter\u00e1 se zam\u011b\u0159uje na terapie a l\u00e9\u010dbu psilocybinem. Jejich studie, kter\u00e9 FDA rovn\u011b\u017e ud\u011blila ozna\u010den\u00ed \"pr\u016flomov\u00e1 terapie\", zahrnuje 80 \u00fa\u010dastn\u00edk\u016f z cel\u00fdch USA trp\u00edc\u00edch MDD (velkou depresivn\u00ed poruchou, co\u017e je klinick\u00fd term\u00edn pro depresi), kte\u0159\u00ed jsou l\u00e9\u010deni jednou d\u00e1vkou psilocybinu. C\u00edlem studie je zkoumat \"psilocybin jako l\u00e9\u010dbu velk\u00e9 depresivn\u00ed poruchy\".<\/p>\n
Mezi touto zkou\u0161kou a zkou\u0161kou, kterou d\u0159\u00edve v tomto roce provedla spole\u010dnost COMPASS, je v\u0161ak obrovsk\u00fd rozd\u00edl, jeho\u017e v\u00fdznam by se nem\u011bl podce\u0148ovat. Studie spole\u010dnosti Usona je ur\u010dena pro obecn\u00e9 pou\u017eit\u00ed psilocybinu jako l\u00e9\u010dby deprese, jako prvn\u00ed volby nebo cesty l\u00e9\u010dby, a nikoli jako posledn\u00ed mo\u017enosti, jak uk\u00e1zaly d\u0159\u00edv\u011bj\u0161\u00ed studie spole\u010dnosti COMPASS. Tato studie v podstat\u011b zkoum\u00e1 \u00fa\u010dinnost psilocybinu jako n\u00e1hrady nebo alternativy v\u011bt\u0161iny typick\u00fdch forem antidepresiv, jako jsou SSRI.<\/p>\n
Podle \u00fa\u0159adu FDA je toto ozna\u010den\u00ed k dispozici na z\u00e1klad\u011b \u017e\u00e1dosti pro jak\u00e9koli klinick\u00e9 hodnocen\u00ed, pokud je mo\u017en\u00e9 p\u0159edlo\u017eit p\u0159edb\u011b\u017en\u00fd d\u016fkaz, \u017ee dan\u00fd l\u00e9k p\u0159edstavuje v\u00fdznamn\u00e9 zlep\u0161en\u00ed oproti ji\u017e existuj\u00edc\u00edm l\u00e9\u010debn\u00fdm postup\u016fm.<\/p>\n
Je to vzru\u0161uj\u00edc\u00ed doba pro v\u0161echny, kdo sd\u00edlej\u00ed zku\u0161enosti s psilocybinem, od rekrea\u010dn\u00edch u\u017eivatel\u016f a\u017e po samol\u00e9\u010ditele, zejm\u00e9na prost\u0159ednictv\u00edm magick\u00fdch hub a lan\u00fd\u017e\u016f, a v\u011bd\u00ed o jeho velk\u00e9m potenci\u00e1lu z l\u00e9ka\u0159sk\u00e9ho i duchovn\u00edho hlediska. To, \u017ee se psilocybin dostal do pop\u0159ed\u00ed sou\u010dasn\u00e9 terapie, by mohlo b\u00fdt pro lidstvo velk\u00fdm krokem vp\u0159ed, proto\u017ee v\u00fdzkum kolem psilocybinu otev\u00edr\u00e1 st\u00e1le nov\u00e9 dve\u0159e a odpov\u00edd\u00e1 na star\u00e9 ot\u00e1zky. Klinick\u00e9 studie, jako jsou ty v\u00fd\u0161e zm\u00edn\u011bn\u00e9, posiluj\u00ed n\u00e1\u0161 z\u00e1pal jako dodavatele magick\u00fdch hub a lan\u00fd\u017e\u016f v\u0161em, kte\u0159\u00ed se sna\u017e\u00ed usilovat!<\/p>","protected":false},"excerpt":{"rendered":"
FDA d\u00e1v\u00e1 psilocybinu v\u00fdznamnou podporu: FDA (americk\u00fd \u00da\u0159ad pro kontrolu potravin a l\u00e9\u010div) letos ji\u017e podruh\u00e9 ud\u011blil klinick\u00e9 studii psilocybinu, halucinogenn\u00ed l\u00e1tky obsa\u017een\u00e9 v magick\u00fdch houb\u00e1ch a lan\u00fd\u017e\u00edch, ozna\u010den\u00ed \"pr\u016flomov\u00e1 terapie\", co\u017e umo\u017e\u0148uje v\u00fdrazn\u011b urychlit obvykle hlem\u00fd\u017ed\u00ed proces.<\/p>","protected":false},"author":4,"featured_media":7068,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[67],"tags":[],"topics":[],"class_list":["post-7060","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-politics-legislation"],"_links":{"self":[{"href":"https:\/\/www.wholecelium.com\/cs\/wp-json\/wp\/v2\/posts\/7060","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.wholecelium.com\/cs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.wholecelium.com\/cs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.wholecelium.com\/cs\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wholecelium.com\/cs\/wp-json\/wp\/v2\/comments?post=7060"}],"version-history":[{"count":1,"href":"https:\/\/www.wholecelium.com\/cs\/wp-json\/wp\/v2\/posts\/7060\/revisions"}],"predecessor-version":[{"id":124041,"href":"https:\/\/www.wholecelium.com\/cs\/wp-json\/wp\/v2\/posts\/7060\/revisions\/124041"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.wholecelium.com\/cs\/wp-json\/wp\/v2\/media\/7068"}],"wp:attachment":[{"href":"https:\/\/www.wholecelium.com\/cs\/wp-json\/wp\/v2\/media?parent=7060"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.wholecelium.com\/cs\/wp-json\/wp\/v2\/categories?post=7060"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.wholecelium.com\/cs\/wp-json\/wp\/v2\/tags?post=7060"},{"taxonomy":"topics","embeddable":true,"href":"https:\/\/www.wholecelium.com\/cs\/wp-json\/wp\/v2\/topics?post=7060"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}